Impact.Tech: Synthetic Immunology with Dr. Alex Marson

​Impact.tech is an initiative by Fifty Years that brings together researchers, founders, and investors to explore the state of science, costs of scaling, and people in the field in an intimate setting. Each seminar lasts 3 hours (5:30pm-8:30pm) and is invite-only. We curate all events such that every conversation and connection made is valuable. 

​Exploring the fundamental workings of the immune system and engineering new cell behaviors and capabilities has enormous implications for treating diseases and advancing our understanding of human health! This Impact.tech seminar on Synthetic Immunology  will dive deep on: How are genome editing and gene therapy technologies being used in synthetic immunology? What are the most promising applications in medicine and healthcare? What are the current challenges facing the field? Who are the main actors in academia and industry working on developing solutions? And more!
Our speaker, Dr. Alex Marson, is a renowned physician and researcher in the field of synthetic immunology at UCSF, and the co-founder of Arsenal Bio and Spotlight Therapeutics. His unparalleled research has focused on the development of cutting-edge CRISPR gene editing technologies to reprogram human immune cells. His discoveries have the potential to revolutionize the treatment of diseases through the development of "living" medicines! 

​Founders, researchers, and investors in bio: whether you're established or just starting to think about Synthetic Immunology, we invite you to join usto connect with other like-minded individuals and explore potential collaborations that could shape the future of healthcare!

​—------

​Fifty Years is a pre-seed/seed stage VC firm that partners with founders solving the world's biggest problems through technology entrepreneurship. We've seeded many synthetic biology startups shaping the world for the better -- companies like Solugen (enzymes to make carbon negative chemicals), Upside Foods (real meat without the animals), Ansa Bio (enzymatic DNA synthesis), and Opentrons (wetlab automation).